ERBB2 and neoplasm: To date, the majority of tumor antigens for directing specificity of CAR T cells have targeted over-expressed proteins, including but not limited to mesothelin, PSMA, PSCA, HER2/neu, EGFR, and IL13Rα2 (3, 5).